Methods and compositions for cellular and metabolic engineering

• US 7,105,297 B2
• Filed: 09/17/2002
• Issued: 09/12/2006
• Est. Priority Date: 02/17/1994
• Status: Expired due to Fees

• Current Assignee: Codexis, Inc.
• Original Assignee: Maxygen Inc.
• Inventors: Minshull, Jeremy, Stemmer, Willem P. C.
• Primary Examiner(s): WHISENANT, ETHAN C
• Application Number:
  US10/244,956
• Publication Number:
  US 20030082611A1
• Time in Patent Office: 1,456 Days
• Field of Search: 435/6, 435/440, 536/23.1, 536/24.3
• US Class Current: 435/6.14
• CPC Class Codes: C07K 14/43595 from coelenteratae, e.g. medusae
• CPC Class Codes: C07K 14/545 IL-1
• CPC Class Codes: C07K 16/00 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/0002
• CPC Class Codes: C07K 2317/565 Complementarity determining region [CDR]
• CPC Class Codes: C07K 2317/622 Single chain antibody (scFv)
• CPC Class Codes: C12N 15/10 Processes for the isolation, preparation or purification of DNA or RNA chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34
• CPC Class Codes: C12N 15/1027 by DNA shuffling, e.g. RSR, STEP, RPR
• CPC Class Codes: C12N 15/1034 Isolating an individual clone by screening libraries
• CPC Class Codes: C12N 15/1037 Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
• CPC Class Codes: C12N 15/52 Genes encoding for enzymes or proenzymes
• CPC Class Codes: C12N 15/64 General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
• CPC Class Codes: C12N 9/2471 Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
• CPC Class Codes: C12N 9/86 acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
• CPC Class Codes: C12Q 1/6811 Selection methods for production or design of target specific oligonucleotides or binding molecules
• CPC Class Codes: C12Q 2525/155 incorporating/generating a new priming site
• CPC Class Codes: C12Q 2525/161 incorporating target specific and non-target specific sites
• CPC Class Codes: C12Y 302/01023 Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
• CPC Class Codes: C40B 40/02 Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors

Abstract

The present invention is generally directed to the evolution of new metabolic pathways and the enhancement of bioprocessing through a process herein termed recursive sequence recombination. Recursive sequence recombination entails performing iterative cycles of recombination and screening or selection to “evolve” individual genes, whole plasmids or viruses, multigene clusters, or even whole genomes. Such techniques do not require the extensive analysis and computation required by conventional methods for metabolic engineering.

Claims

1. A method of recombining nucleic acids, comprising:

introducing a set of nucleic acids encoding at least one protein into a set of cells;

recombining the set of nucleic acids in the set of cells by multiple rounds of nucleic acid transfer between members of the set of cells or progeny thereof and recombination of members of the set of nucleic acids or recombination products thereof within the set of cells or progeny thereof, thereby producing recombinant nucleic acids encoding recombinant proteins; and

screening said recombinant nucleic acids encoding recombinant proteins for one or more desired property.

2. The method of claim 1, wherein introducing the nucleic acids into the cells or the transfer of the set of nucleic acids by multiple rounds of nucleic acid transfer comprises packaging the nucleic acids or the set of nucleic acids in one or more viral vectors.

3. The method of claim 1, comprising recombining the recombinant nucleic acids in vitro, or wherein the set of nucleic acids comprises one or more members produced by in vitro recombination of one or more initial nucleic acids.

4. The method of claim 1, comprising recombining the recombinant nucleic acids in vivo, or wherein the set of nucleic acids comprises one or more members produced by in vivo recombination of one or more initial nucleic acids.

5. The method of claim 1, wherein at least one member of the set of cells is selected or derived from one or more of:

a bacterial cell gram-negative cell, gram-positive cell, a Streptomycetes cell, an Actinomycetes cell, a Corynebacteria cell, a Penicillium cell, a Bacillus cell, an Escherichia coli cell, a Pseudomonas cell, a Salmonella cell, an Erwinia cell, a eukaryotic cell a mammalian cell, a mouse cell, a hamster cell, a primate cell, a human cell, an established cell line cell, a primary cell culture cell, a stem cell, an embryonic stem cell, a zygote cell, a fibroblast cell, a lymphocyte cell, a Chinese hamster ovary (CHO) cell, a mouse fibroblast cell, an NIH3T3 cell, a kidney cell, a liver cell, a muscle cell, a skin cell, a plant cell, a maize cell, a Ace cell, a wheat cell, a cotton cell, a soybean cell, a sugarcane cell, a tobacco cell, an arabidopsis cell;

a fish cell, an algal cell, a fungal cell, a Penicillium cell a Fusarium cell, an Aspergillus cell, a Podospora cell, a Neurospora cell, an insect cell, a yeast cell, a Picchia cell, a Saccharomyces cell, or a nitrogen-fixation symbiotic cell.

6. The method of claim 1, wherein at least one member of the set of cells is selected or derived from a tissue or organism selected from the group consisting of:

a plant, a bacteria, a fungus, an algae, an intact animal tissue, a tissue culture, and an animal embryo.

7. The method of claim 1, wherein the set of nucleic acids comprises one or more of:

a plasmid, a cosmid, a chromosome, an episome, a YAC, a phage, a filamentous phage, a phage P1 clone, or a viral vector.

8. The method of claim 1, wherein the set of nucleic acids comprises one or more of:

an acylase, a dioxygenase, a monooxygenase, a carotenoid synthetic enzyme, a hydrolytic enzyme, a catabolic enzyme, a dibenzothiopene catabolizing enzyme, a nitroreductase, a benzene degrading enzyme, a nitrobenzene degrading enzyme, a nitrotoluene degrading enzyme, a toxin degrading enzyme, an industrial chemical degrading enzyme, an herbicide degrading enzyme, a cellulose degrading enzyme, a pesticide degrading enzyme a pollutant degrading enzyme, a xylene degrading enzyme a toluene degrading enzyme, a camphor degrading enzyme, a naphthalene degrading enzyme, a halogenated hydrocarbon degrading enzyme, a biphenyl degrading enzyme, a polychlorinated biphenyl (PCB) degrading enzyme, a polycyclic aromatic hydrocarbon (PHA) degrading enzyme, a polyhydroxybutyrate (PHB) degrading enzyme, a trichloroethylene degrading enzyme, a pentachlorophenyl (PCP) degrading enzyme, a trichloroethylene degrading enzyme, a paranitrobenzyl, esterase, a sesquiterpene synthase, an expandase, a penicillin amidase, a penicillin G amidase, an enzyme which modifies 7-aminodeacetooxycephalosporanic acid (7-ADCA), an enzyme which modifies a semi-synthetically produced cephalosporin, and an enzyme which modifies penicillin V.

9. The method of claim 1, wherein the recombinant nucleic acid provides an organism, when expressed in the organism, with improved property selected from the group consisting of:

an improved ability to utilize a nutrient source, an improved ability to produce a metabolic intermediate, or an improved ability to provide bioremediation or biodegradation of one or more toxin, industrial chemical, herbicide, pesticide or pollutant.